Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HCNC

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private, Subsidiary

Established: 1977-01-01

Employees: 1K

Market Cap: -

Website: http://www.uzbrussel.be

Clinical Trials

Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist

Phase 4

Completed

Conditions: Reproductive Endocrinology
Fertility
Optimal Stimulation Protocol

Interventions: Drug: GnRH agonist
Drug: GnRH antagonist
Drug: hP-hMG
Drug: Human chorionic gonadotropin
Drug: Progesterone

First Posted Date: 2013-06-28

Last Posted Date: 2013-06-28

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 120

Registration Number: NCT01888744

Locations: 🇧🇪
Centre for Reproductive Medicine, Brussels, Belgium

Corifollitropin Alfa Followed by Menotropin for Poor Ovarian Responders Trial

Phase 3

Completed

Conditions: Poor Ovarian Response
Infertility

Interventions: Drug: recombinant FSH
Drug: Corifollitropin alfa
Drug: Ganirelix
Drug: hp HMG

First Posted Date: 2013-03-22

Last Posted Date: 2016-06-23

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 150

Registration Number: NCT01816321

Locations: 🇧🇪
Universitair Ziekenhuis Brussel, Brussels, Belgium
🇻🇳
University of Medicine and Pharmacy of Ho Chi Minh City, Ho Chi Minh City, Vietnam

HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)

Phase 4

Conditions: Endometrial Thickness
Pregnancy Outcome

Interventions: Drug: HCG (human chorionic gonadotropin)

First Posted Date: 2013-01-15

Last Posted Date: 2013-01-17

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 15

Registration Number: NCT01768247

Locations: 🇬🇷
HRG Foundation, Thessaloniki, Kalamaria, Greece

Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders

Phase 2

Completed

Conditions: Infertility
Poor Ovarian Response

Interventions: Drug: Triptorelin
Drug: Corifollitropin alfa 150μg
Drug: hpHMG

First Posted Date: 2012-11-22

Last Posted Date: 2013-05-09

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 57

Registration Number: NCT01732094

Locations: 🇧🇪
Centre for Reproductive Medicine UZ Brussel, Brussels, Belgium

Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

Phase 2

Completed

Conditions: Infertility
Poor Ovarian Response

Interventions: Drug: Triptorelin
Drug: Corifollitropin alfa
Drug: hpHMG

First Posted Date: 2012-11-22

Last Posted Date: 2013-05-09

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 51

Registration Number: NCT01732068

Locations: 🇧🇪
Centre for Reproductive Medicine UZ Brussel, Brussels, Belgium

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

Phase 2

Completed

Conditions: Malignant Melanoma Stage IV
Malignant Melanoma Stage III

Interventions: Biological: Dendritic cell therapy

First Posted Date: 2012-08-31

Last Posted Date: 2017-05-24

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 88

Registration Number: NCT01676779

Locations: 🇧🇪
UZ Brussel, Brussel, Belgium

D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists

Phase 4

Completed

Conditions: Infertility

Interventions: Drug: corifollitropin alfa

First Posted Date: 2012-07-04

Last Posted Date: 2014-12-03

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 67

Registration Number: NCT01633580

Locations: 🇧🇪
UZ Brussel, Jette, Belgium

Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak

Phase 4

Completed

Conditions: Pregnancy

Interventions: Procedure: intra-uterine insemination

First Posted Date: 2012-06-18

Last Posted Date: 2019-04-19

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 435

Registration Number: NCT01622023

Locations: 🇧🇪
Christophe Blockeel, Brussel, Belgium

HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles

Early Phase 1

Completed

Conditions: Spontaneous Triggering of Ovulation vs. Administration of Human Chorionic Gonadotropin in Patients Undergoing IUI

Interventions: Drug: HCG

First Posted Date: 2011-08-11

Last Posted Date: 2011-08-11

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 300

Registration Number: NCT01414673

Locations: 🇧🇪
Uzbrussel, Brussel, Laarbeeklaan 101, Belgium

Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles

Phase 2

Completed

Conditions: hCG

Interventions: Other: 16mm triggering

First Posted Date: 2011-07-08

Last Posted Date: 2011-08-04

Lead Sponsor: Universitair Ziekenhuis Brussel

Target Recruit Count: 100

Registration Number: NCT01390207

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy